SEC Form D private-offering filing

Consano Bio, Inc.

Name: Consano Bio, Inc. - new SEC Form D private-offering filing, Burlington, MA
Published: 2025-12-12

A new SEC Form D private-offering notice from Burlington, MA, a $16,840,000 filer-stated offering target in Biotech. The source filing is one click away.

Consano Bio, Inc. site↗ Verified via SEC Form D

Clinical stage biotech developing non opioid therapeutics for chronic orthopedic pain conditions, lead candidate C-1101 for chronic sciatica

Filed 2025-12-12Filed to raise $16,840,000First money in 2024-10-15Raised so far $16,840,000HQ (as filed) Burlington, MASector Biotech ✓Stage (inferred) EarlyCall status Late filing

Source linked the Form D on EDGAR↗Website verified consanobio.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.